Riskpilot← Back to searchSign inGet full accessPharmacy House Oy Ab
OYActiveY-tunnus 3144955-6Hovioikeudenpuistikko 9Beverage serving activities · NACE 5630Est. 20206 employeeswww.pharmacyhousecafe.fi
Revenue 2024
EUR 516K
+15% vs 2023
EBITDA margin
7.7%
+52% vs 2023
Equity ratio
2.4%
Financial strength
Net profit 2024
EUR 22K
+239% vs 2023
| Revenue | EUR 516K | +15% |
| EBITDA | EUR 40K | +52% |
| Net profit | EUR 22K | +239% |
| Total assets | EUR 116K | +14% |
| Equity | EUR 3K | +114% |
| Employees | 6 | — |
Legal name
Pharmacy House Oy Ab
Y-tunnus number
3144955-6
Legal form
Osakeyhtiö
NACE code
5630 · Beverage serving activities
Founded
1. heinäkuuta 2020
Share capital
EUR 6 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Föremål för bolagets verksamhet Föremål för bolagets verksamhet är att bedriva café-, restaurang- och bageriverksamhet samt att idka annan därmed förenlig verksamhet inom livsmedelsbranschen. Bolaget kan även äga och idka handel med fastigheter och värdepapper.
Address
Hovioikeudenpuistikko 9
Email
cafe@pharmacyhousecafe.fi
Website
www.pharmacyhousecafe.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 389 | 448 | 516 |
| Staff expenses | −161 | −203 | −230 |
| EBITDA | 48 | 26 | 40 |
| Depreciation & amort. | −14 | −13 | −13 |
| EBIT | 34 | 13 | 27 |
| Net financials | −5 | −6 | −5 |
| Profit before tax | 29 | 6 | 22 |
| Tax | −0 | −0 | −0 |
| Net profit | 29 | 6 | 22 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 121 | 101 | 116 |
| Equity | −26 | −19 | 3 |
| Long-term debt | 74 | 51 | 23 |
| Short-term debt | 73 | 51 | 61 |
| Total debt | 147 | 130 | 113 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20222024
Equity ratio
2.4%
This company
38.2%
Market median
-94% vs market
20222024
Return on equity
802.6%
This company
18.4%
Market median
+4262% vs market
20222024
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
20222024
Asset turnover
4.46×
This company
1.12×
Market median
+298% vs market
20222024
Debt / equity
41.54×
This company
0.62×
Market median
-6600% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JA Chief Executive Officer | Chief Executive Officer | 2020 |
SR Deputy auditor | Deputy auditor | 2025 |
HJ Audit | Audit | 2025 |
| Former (1) | ||
IJ Audit | Audit | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2020 | |
| Chairperson | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmacy House Oy Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jessica Ann-Kristin Piispanen | Chief Executive Officer | 0 companies |
| Ingela Josefin Tåg | Audit | 0 companies |
| Stefan Rolf Axel Wiklund | Deputy auditor | 0 companies |
| Hans Jan Anders Jåfs | Audit | 0 companies |
| Olena Omelianenko | Board of Directors | 0 companies |
| Juha Paavo Nuutila | Board of Directors | 0 companies |
| Ditte Mai Nuutila | Chairperson | 0 companies |
| Jan Peter Mikael Piispanen | Board of Directors | 0 companies |